Finance Monthly M&A Awards 2019 - Winners Edition

16 Lead Financial Adviser to AbbVie Legal Advisers to AbbVie Exclusive Financial Adviser to Allergan ABBVIE ACQUIRE ALLERGAN FOR $63BN USA MERGERS & ACQUISITIONS Pharmaceutical INTRODUCTION The AbbVie Board and the Independent Allergan Directors announced that they have reached agreement on the terms of a recommended acquisition of Allergan in a transaction valued at approximately $63 billion of equity value. The Acquisition will be effected by means of a Scheme under Chapter 1 of Part 9 of the Act. DEAL OF THE YEAR 2019